For tumors in organs like the liver, kidney, prostate, or breast that are difficult to visualize with ultrasound or CT, MRI offers superior soft-tissue contrast and precise targeting, reducing repeat procedures and improving diagnostic confidence.
Precision biopsy and focal therapy, without radiation
Interventional MRI (iMRI) transforms how clinicians approach biopsy and focal therapy. With real-time, high-resolution imaging and no ionizing radiation, iMRI enables precise targeting of small or deep-seated lesions, improving diagnostic confidence and therapeutic outcomes (in selected cancers).
For interventional radiologists and oncologists, iMRI opens new procedural possibilities, especially in anatomically complex or previously inaccessible regions. It supports early detection, accurate tissue sampling, and minimally invasive treatment with reduced risk and patient comfort in mind.
Patients with challenging or deep-seated lesions
Radiation-sensitive or vulnerable populations
Pediatric patients, pregnant individuals, and those requiring multiple imaging sessions benefit from MRI’s radiation-free approach, without compromising accuracy.
Patients with prior negative or inconclusive biopsies
When conventional methods fail to confirm a diagnosis, MRI-guided biopsy provides enhanced visibility and precision, helping clinicians detect clinically significant disease and avoid repeat procedures.
MRI-guided interventions are already being used for the following:
- targeting liver, kidney, and prostate lesions
- treating small focal tumors in challenging locations
- performing repeat biopsies with reduced patient burden
"iMRI has entered into clinical routine at our facility and means an epic change for biopsy and treatment of liver tumors."
Built for clinical impact and institutional sustainability
The iMRI Suite aligns advanced image-guided intervention with existing procedural and reimbursement pathways (subject to local policy).
With cross-specialty utilization and 24/7 imaging potential, it supports both patient outcomes and operational performance.
View economic framework